Trials / Recruiting
RecruitingNCT06645379
Application of Platelet-rich Plasma (PRP) in Reproductive Medicine
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Female fertility is affected by many factors, such as ovarian function, fallopian tube patency, uterine environment, and mental state, among which the ovaries and endometrium are more important. In reproductive medicine, ovarian dysfunction, poor ovarian reaction, intrauterine adhesion, recurrent implantation failure, and thin endometrium are the five most common diseases that affect fertility. These five diseases lack effective treatment, and previous studies have shown that platelet-rich plasma is promising in treating these five diseases, so it is necessary to further explore the therapeutic effect and potential mechanism.
Conditions
- Premature Ovarian Insufficiency
- Intrauterine Adhesion
- Poor Ovarian Response
- Repeated Implantation Failure
- Thin Endometrium
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Platelet-Rich Plasma (PRP) Injections | Transvaginal or laparoscopic injection for ovarian diseases (Premature ovarian insufficiency and Poor ovarian response). Intrauterine perfusion or sub-endometrium injection for uterine diseases (intrauterine adhesion, thin endometrium, and repeated implantation failure) |
Timeline
- Start date
- 2024-10-17
- Primary completion
- 2027-09-15
- Completion
- 2027-09-15
- First posted
- 2024-10-16
- Last updated
- 2025-02-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06645379. Inclusion in this directory is not an endorsement.